Dynamic Practice Simulation (DPS®) Line of Therapy
DPS Line of Therapy provides you with a more flexible, granular look at your market
RG+A's simulation-based marketing research tool,
DPS Line of Therapy, engages physicians to treat simulated patients under current and future market conditions, thus allowing you to account for a range of market events, including new competitors, clinical trial outcomes, and changes in the market environment.
Key Benefits of DPS Line of Therapy
Peak shares both overall and by line of therapy
Clarity on most likely patients
Details on source of share
Impact of additional clinical data and additional competitive entrant on the new product
Greater precision in forecasting over allocation patient chart audit approaches
Guidance on treatment sequencing and combination use